Sachetta LLC Has $29,000 Holdings in Xenetic Biosciences Inc (NASDAQ:XBIO)

Sachetta LLC trimmed its stake in shares of Xenetic Biosciences Inc (NASDAQ:XBIO) by 57.6% during the fourth quarter, Holdings Channel.com reports. The firm owned 7,371 shares of the company’s stock after selling 10,000 shares during the period. Sachetta LLC’s holdings in Xenetic Biosciences were worth $29,000 at the end of the most recent reporting period.

Xenetic Biosciences Price Performance

Shares of NASDAQ:XBIO opened at $4.24 on Friday. The company has a 50 day moving average of $4.16 and a 200-day moving average of $4.00. Xenetic Biosciences Inc has a one year low of $2.78 and a one year high of $5.20. The stock has a market cap of $6.54 million, a price-to-earnings ratio of -1.59 and a beta of 2.22.

Xenetic Biosciences (NASDAQ:XBIO) last released its earnings results on Tuesday, November 12th. The company reported ($0.28) EPS for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.14). The business had revenue of $0.61 million for the quarter, compared to analyst estimates of $0.75 million. Xenetic Biosciences had a negative return on equity of 49.51% and a negative net margin of 161.63%. Equities research analysts anticipate that Xenetic Biosciences Inc will post -1.01 earnings per share for the current year.

Analyst Upgrades and Downgrades

Separately, HC Wainwright reiterated a “neutral” rating on shares of Xenetic Biosciences in a research report on Thursday, December 5th.

About Xenetic Biosciences

Xenetic Biosciences, Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The Company is initially advancing cell-based therapeutics targeting the unique B-cell receptor on the surface of an individual patient’s malignant tumor cells for the treatment of B-cell lymphomas.